{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:25:08Z","timestamp":1779384308423,"version":"3.53.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6662","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[1998,1]]},"DOI":"10.1038\/34184","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:37:12Z","timestamp":1027672632000},"page":"82-86","source":"Crossref","is-referenced-by-count":1683,"title":["PPAR-\u03b3 agonists inhibit production of monocyte inflammatory cytokines"],"prefix":"10.1038","volume":"391","author":[{"given":"Chengyu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian T.","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Seed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[1998,1,1]]},"reference":[{"key":"BF34184_CR1","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","volume":"83","author":"DJ Mangelsdorf","year":"1995","unstructured":"Mangelsdorf, D. J. et al. The nuclear receptor superfamily: the second decade. Cell 83, 835\u2013839 (1995).","journal-title":"Cell"},{"key":"BF34184_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev.cellbio.12.1.335","volume":"12","author":"T Lemberger","year":"1996","unstructured":"Lemberger, T., Desvergne, B. & Wahli, W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell Dev. Biol. 12, 335\u2013363 (1996).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"BF34184_CR3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1210\/endo.135.2.8033830","volume":"135","author":"A Chawla","year":"1994","unstructured":"Chawla, A., Schwarz, E. J., Dimaculangan, D. D. & Lazar, M. A. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135, 798\u2013800 (1994).","journal-title":"Endocrinology"},{"key":"BF34184_CR4","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","volume":"8","author":"P Tontonoz","year":"1994","unstructured":"Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I. & Spiegelman, B. M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224\u20131234 (1994).","journal-title":"Genes Dev."},{"key":"BF34184_CR5","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/0092-8674(94)90006-X","volume":"79","author":"P Tontonoz","year":"1994","unstructured":"Tontonoz, P., Hu, E. & Spiegelman, B. M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79, 1147\u20131156 (1994).","journal-title":"Cell"},{"key":"BF34184_CR6","doi-asserted-by":"publisher","first-page":"9856","DOI":"10.1073\/pnas.92.21.9856","volume":"92","author":"E Hu","year":"1995","unstructured":"Hu, E., Tontonoz, P. & Spiegelman, B. M. Transdifferentiation by myoblasts by the adipogenic transcription factor PPAR gamma and C\/EBP alpha. Proc. Natl Acad. Sci. USA 92, 9856\u20139860 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF34184_CR7","doi-asserted-by":"publisher","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","volume":"270","author":"JM Lehmann","year":"1995","unstructured":"Lehmann, J. M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270, 12953\u201312956 (1995).","journal-title":"J. Biol. Chem."},{"key":"BF34184_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","volume":"83","author":"SA Kliewer","year":"1995","unstructured":"Kliewer, S. A. et al. Aprostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83, 813\u2013819 (1995).","journal-title":"Cell"},{"key":"BF34184_CR9","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","volume":"83","author":"BM Forman","year":"1995","unstructured":"Forman, B. M. et al. 15-Deoxy-delta 12,14-porostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83, 803\u2013812 (1995).","journal-title":"Cell"},{"key":"BF34184_CR10","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1074\/jbc.272.6.3406","volume":"272","author":"JM Lehmann","year":"1997","unstructured":"Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M. & Kliewer, S. A. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272, 3406\u20133410 (1997).","journal-title":"J. Biol. Chem."},{"key":"BF34184_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil, G. S., Shargill, N. S. & Spiegelman, B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87\u201391 (1993).","journal-title":"Science"},{"key":"BF34184_CR12","doi-asserted-by":"publisher","first-page":"8313","DOI":"10.1073\/pnas.83.21.8313","volume":"83","author":"JS Patton","year":"1986","unstructured":"Patton, J. S. et al. Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. Proc. Natl Acad. Sci. USA 83, 8313\u20138317 (1986).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF34184_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1083\/jcb.108.3.1105","volume":"108","author":"FM Torti","year":"1989","unstructured":"Torti, F. M., Torti, S. V., Larrick, J. W. & Ringold, G. M. Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta. J. Cell Biol. 108, 1105\u20131113 (1989).","journal-title":"J. Cell Biol."},{"key":"BF34184_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/endo.135.1.8013346","volume":"135","author":"MK Marshall","year":"1994","unstructured":"Marshall, M. K., Doerrler, W., Feingold, K. R. & Grunfeld, C. Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes. Endocrinology 135, 141\u2013147 (1994).","journal-title":"Endocrinology"},{"key":"BF34184_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/1043-4666(94)90067-1","volume":"6","author":"M Berg","year":"1994","unstructured":"Berg, M., Fraker, D. L. & Alexander, H. R. Characterization of differentiation factor\/leukaemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes. Cytokine 6, 425\u2013432 (1994).","journal-title":"Cytokine"},{"key":"BF34184_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1210\/endo.130.1.1727716","volume":"130","author":"CH Lang","year":"1992","unstructured":"Lang, C. H., Dobrescu, C. & Bagby, G. J. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic gluose output. Endocrinology 130, 43\u201352 (1992).","journal-title":"Endocrinology"},{"key":"BF34184_CR17","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1210\/endo.136.4.7895657","volume":"136","author":"D Szalkowski","year":"1995","unstructured":"Szalkowski, D., White-Carrington, S., Berger, J. & Zhang, B. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology 136, 1474\u20131481 (1995).","journal-title":"Endocrinology"},{"key":"BF34184_CR18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1210\/endo.137.1.8536636","volume":"137","author":"O Braissant","year":"1996","unstructured":"Braissant, O., Foufelle, F., Scotto, C., Dauca, M. & Wahli, W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137, 354\u2013366 (1996).","journal-title":"Endocrinology"},{"key":"BF34184_CR19","first-page":"281","volume":"4","author":"ME Greene","year":"1995","unstructured":"Greene, M. E. et al. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Express. 4, 281\u2013299 (1995).","journal-title":"Gene Express."},{"key":"BF34184_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/384039a0","volume":"384","author":"PR Devchand","year":"1996","unstructured":"Devchand, P. R. et al. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384, 39\u201343 (1996).","journal-title":"Nature"},{"key":"BF34184_CR21","doi-asserted-by":"publisher","first-page":"23975","DOI":"10.1074\/jbc.270.41.23975","volume":"270","author":"K Yu","year":"1995","unstructured":"Yu, K. et al. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270, 23975\u201323983 (1995).","journal-title":"J. Biol. Chem."},{"key":"BF34184_CR22","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1016\/S0021-9258(18)53294-4","volume":"268","author":"EA Meade","year":"1993","unstructured":"Meade, E. A., Smith, W. L. & DeWitt, D. L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268, 6610\u20136614 (1993).","journal-title":"J. Biol. Chem."},{"key":"BF34184_CR23","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/rheumatology\/32.11.982","volume":"32","author":"CS Lau","year":"1993","unstructured":"Lau, C. S., Morley, K. D. & Belch, J. J. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis\u2014a double-blind placebo controlled study. Br. J. Rheumatol. 32, 982\u2013989 (1993).","journal-title":"Br. J. Rheumatol."},{"key":"BF34184_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","volume":"14","author":"M Feldmann","year":"1996","unstructured":"Feldmann, M., Brennan, F. M. & Maini, R. N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14, 397\u2013440 (1996).","journal-title":"Annu. Rev. Immunol."},{"key":"BF34184_CR25","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/S0952-7915(96)80018-5","volume":"8","author":"FM Brennan","year":"1996","unstructured":"Brennan, F. M. & Feldman, M. Cytokines in autoimmunity. Curr. Opin. Immunol. 8, 872\u2013877 (1996).","journal-title":"Curr. Opin. Immunol."},{"key":"BF34184_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1056\/NEJM199707173370301","volume":"337","author":"LW Moreland","year":"1997","unstructured":"Moreland, L. W. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337, 141\u2013147 (1997).","journal-title":"N. Engl. J. Med."},{"key":"BF34184_CR27","volume-title":"AHFS 97 Drug Information","author":"GK McEvoy","year":"1997","unstructured":"McEvoy, G. K. (ed) AHFS 97 Drug Information (American Society of Health-Systems Pharmacists, Bethesda, MD, (1997))."},{"key":"BF34184_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1056\/NEJM199707173370310","volume":"337","author":"GS Firestein","year":"1997","unstructured":"Firestein, G. S. & Zvaifler, N. J. Anticytokine therapy in rheumatoid arthritis. N. Engl. J. Med. 337, 195\u2013197 (1997).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/34184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/34184","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/34184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T01:46:07Z","timestamp":1684287967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/34184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":28,"journal-issue":{"issue":"6662","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["BF34184"],"URL":"https:\/\/doi.org\/10.1038\/34184","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}